Written by: Professor Malcolm Carruthers
If, following a blood test, other investigations and information gathering the doctor considers that the patient may be suffering from testosterone deficiency syndrome he will discuss the benefits and potential risks of testosterone replacement therapy (TRT) or other testosterone treatment with him. If treatment is indicated and the patient wishes to proceed, a trial period of TRT or testosterone stimulation therapy will be initiated.
TRT is usually given by testosterone gel, cream or long acting injections. Testosterone Replacement Therapy (TRT) has been shown to be highly effective in relieving the symptoms of testosterone deficiency – in particular in restoring energy, health and sex drive.
TRT is usually given as a gel or injection for the first two to six months. It is often needed long-term, and can safely be continued in these forms if good symptom relief is maintained, or changed to other types if needed. Testosterone treatment has been in use for over half a century, and has a remarkably good safety record over that time, as confirmed by the detailed studies at this centre. However, every effort is made to exclude pre-existing prostatic cancer, by clinical examination, and a sensitive blood test, the Prostate Specific Antigen (PSA).
To ensure the safety and effectiveness of treatment, it is essential that the results of treatment are carefully monitored. Both to establish the diagnosis and to monitor the treatment carefully, blood tests and laboratory measurements are required at regular intervals. Following the initial consultation and diagnosis, detailed clinical examinations need to be carried out at 3-6 month intervals.